ZA201009085B - Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors - Google Patents

Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors

Info

Publication number
ZA201009085B
ZA201009085B ZA2010/09085A ZA201009085A ZA201009085B ZA 201009085 B ZA201009085 B ZA 201009085B ZA 2010/09085 A ZA2010/09085 A ZA 2010/09085A ZA 201009085 A ZA201009085 A ZA 201009085A ZA 201009085 B ZA201009085 B ZA 201009085B
Authority
ZA
South Africa
Prior art keywords
tumors
treatment
tyrosine kinase
kinase modulators
dihydropyrazole derivatives
Prior art date
Application number
ZA2010/09085A
Other languages
English (en)
Inventor
Dieter Dorsch
Oliver Schadt
Frank Stieber
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA201009085B publication Critical patent/ZA201009085B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2010/09085A 2008-05-29 2010-12-17 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors ZA201009085B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008025750A DE102008025750A1 (de) 2008-05-29 2008-05-29 Dihydropyrazolderivate
PCT/EP2009/003030 WO2009143945A1 (de) 2008-05-29 2009-04-24 Dihydropyrazolderivate als tyrosinkinase modulatoren zur behandlung von tumoren

Publications (1)

Publication Number Publication Date
ZA201009085B true ZA201009085B (en) 2011-10-26

Family

ID=40822993

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/09085A ZA201009085B (en) 2008-05-29 2010-12-17 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors

Country Status (16)

Country Link
US (1) US8404685B2 (OSRAM)
EP (1) EP2300434B1 (OSRAM)
JP (1) JP5643192B2 (OSRAM)
KR (1) KR20110010821A (OSRAM)
CN (1) CN102046605B (OSRAM)
AR (1) AR071951A1 (OSRAM)
AU (1) AU2009253432B2 (OSRAM)
BR (1) BRPI0912970A2 (OSRAM)
CA (1) CA2726009C (OSRAM)
DE (1) DE102008025750A1 (OSRAM)
EA (1) EA018394B1 (OSRAM)
ES (1) ES2507573T3 (OSRAM)
IL (1) IL209418A (OSRAM)
MX (1) MX2010012804A (OSRAM)
WO (1) WO2009143945A1 (OSRAM)
ZA (1) ZA201009085B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2796774T3 (es) 2011-07-01 2020-11-30 Merck Patent Gmbh Dihidropirazoles, composiciones farmacéuticas de los mismos y su uso para el tratamiento de trastornos de fertilidad
CA2878621C (en) * 2012-07-10 2020-09-15 Ares Trading S.A. Pyrimidine pyrazolyl derivatives
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
DE69709319T2 (de) 1996-03-05 2002-08-14 Astrazeneca Ab, Soedertaelje 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
CN1431999A (zh) 2000-05-31 2003-07-23 阿斯特拉曾尼卡有限公司 具有血管损伤活性的吲哚衍生物
RU2003103603A (ru) 2000-07-07 2004-08-20 Энджиоджен Фармасьютикалз Лимитед (Gb) Производные колхинола в качестве ингибиторов ангиогенеза
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
JP4399269B2 (ja) * 2002-03-08 2010-01-13 メルク エンド カムパニー インコーポレーテッド 有糸分裂性キネシン阻害薬
DE102005038537A1 (de) 2005-08-16 2007-02-22 Merck Patent Gmbh 1-Acyldihydropyrazolderivate

Also Published As

Publication number Publication date
CN102046605B (zh) 2013-09-18
IL209418A (en) 2015-09-24
US20110071153A1 (en) 2011-03-24
AR071951A1 (es) 2010-07-28
JP5643192B2 (ja) 2014-12-17
HK1157345A1 (en) 2012-06-29
AU2009253432B2 (en) 2013-08-01
IL209418A0 (en) 2011-01-31
EA201001831A1 (ru) 2011-06-30
KR20110010821A (ko) 2011-02-07
CA2726009C (en) 2016-08-23
BRPI0912970A2 (pt) 2015-10-13
EP2300434A1 (de) 2011-03-30
US8404685B2 (en) 2013-03-26
DE102008025750A1 (de) 2009-12-03
EA018394B1 (ru) 2013-07-30
AU2009253432A1 (en) 2009-12-03
JP2011520996A (ja) 2011-07-21
CA2726009A1 (en) 2009-12-03
MX2010012804A (es) 2010-12-07
EP2300434B1 (de) 2014-07-23
WO2009143945A1 (de) 2009-12-03
CN102046605A (zh) 2011-05-04
ES2507573T3 (es) 2014-10-15

Similar Documents

Publication Publication Date Title
ZA201000085B (en) 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumors
SI2120932T1 (sl) Indazolni derivati kot kinazni inhibitorji za zdravljenje raka
AU2009270856A8 (en) Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
ZA201201627B (en) Compounds as tyrosine kinase modulators
PT2303021T (pt) Compostos para tratamento do cancro
EP2063897A4 (en) KINASEHEMMER FOR THE TREATMENT OF PROLIFERATIVE DISEASES
EP2063896A4 (en) KINASEHEMMER FOR THE TREATMENT OF PROLIFERATIVE DISEASES
SI2646432T1 (sl) Substituirani derivati benzopirazina kot inhibitorji FGFR kinaz za zdravljenje rakavih bolezni
IL213070A0 (en) Methods for the treatment of infections and tumors
IL195152A0 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
SI2356101T1 (sl) Pirimidin- in triazin-sulfonamidni derivati kot inhibitorji bradikininskega B1 receptorja (B1R)
AP2886A (en) 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
IL209840A0 (en) Azacarboline derivatives, preparation thereof, and therapeutic use thereof as kinase inhibitors
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
EP2247185A4 (en) INHIBITORS OF TYROSINE KINASE
IL210214A (en) A process for preparing converted pyrimidine annals and such new compounds
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
PL2331092T3 (pl) Sposoby i kompozycje do podawania 3-halopirogronianiu i związków pochodnych w leczeniu nowotworu
ZA201009085B (en) Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
ZA201007729B (en) Use of corticotropin-releasing factor for the treatment of cancer
HK1200814A1 (zh) 雜環化合物及其作為iii型受體酪氨酸激酶調節劑的用途
HK1149475A (en) Use of corticotropin-releasing factor for the treatment of cancer
HK1162949A (zh) 治療癌症的組合療法